Pediatric Neurosurgery
Original Paper
Long-Term Outcome after Treatment of Hydrocephalus in ChildrenAppelgren T.a · Zetterstrand S.c · Elfversson J.a, b · Nilsson D.a, baInstitute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, and bDepartment of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, and cAstraZeneca R&D, Mölndal, Sweden
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: February 15, 2010
Accepted: July 13, 2010
Published online: November 04, 2010
Issue release date: November 2010
Number of Print Pages: 6
Number of Figures: 4
Number of Tables: 2
ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)
For additional information: https://www.karger.com/PNE
Abstract
Aims: To provide long-term outcome data after treatment of hydrocephalus in children, and to identify risk factors for ventriculoperitoneal shunt (VPS) failure. Methods: Endoscopic third ventriculostomy (ETV) and VPS procedures in children between 2001 and 2005 were reviewed. Data collected prospectively included age at surgery, sex, aetiology of hydrocephalus, gestational age, emergency/planned surgery, duration of surgery, time of day, surgeon’s experience and other concomitant surgery. The mean follow-up was 4.7 years (min. 2 years). The endpoint was a new surgery due to failure of treatment, and the time to failure was noted. Risk factors for VPS failure were analysed by univariate Cox proportional hazards regression. Results: Ninety-eight patients were included, 76 with a VPS, 22 with an ETV. Fifty-five percent of ETV and 58% of VPS failed. Significant risk factors (p < 0.05) for VPS failure were prematurity (HR: 2.05; 95% CI: 1.12–3.76), concomitant procedure (HR: 2.07; 95% CI: 1.04–4.12) and long duration of surgery (HR: 1.23; 95% CI: 1.06–1.44), while sex, surgeon’s experience, shunt type, at what department the surgery was performed, whether the surgery was acute or elective, and time of day were not. Conclusion: Treatment failure occurred in >50% of patients after ETV and VPS. Prematurity and concomitant surgery were major risk factors for VPS failure.
© 2010 S. Karger AG, Basel
Related Articles:
References
-
Stein SC, Guo W: Have we made progress in preventing shunt failure? A critical analysis. J Neurosurg Pediatr 2008;1:40–47.
External Resources
- de Ribaupierre S, Rilliet B, Vernet O, Regli L, Villemure JG: Third ventriculostomy vs ventriculoperitoneal shunt in pediatric obstructive hydrocephalus: results from a Swiss series and literature review. Childs Nerv Syst 2007;23:527–533.
- Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, Piatt J, Haines S, Schiff S, Cochrane D, Steinbok P, MacNeil N: Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 2000;33:230–236.
- McGirt MJ, Leveque JC, Wellons JC 3rd, Villavicencio AT, Hopkins JS, Fuchs HE, George TM: Cerebrospinal fluid shunt survival and etiology of failures: a seven-year institutional experience. Pediatr Neurosurg 2002;36:248–255.
- Tuli S, Drake J, Lawless J, Wigg M, Lamberti-Pasculli M: Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. J Neurosurg 2000;92:31–38.
- Drake JM: Endoscopic third ventriculostomy in pediatric patients: the Canadian experience. Neurosurgery 2007;60:881–886, discussion 881–886.
- Tuli S, Alshail E, Drake J: Third ventriculostomy versus cerebrospinal fluid shunt as a first procedure in pediatric hydrocephalus. Pediatr Neurosurg 1999;30:11–15.
-
Socialstyrelsen: Klassifikation av kirurgiska åtgärder 1997, ed 2. Stockholm, Swedish National Board of Health and Welfare, 2004.
- Kulkarni AV, Drake JM, Mallucci CL, Sgouros S, Roth J, Constantini S: Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus. J Pediatr 2009;155:254–259.e1.
- Albright AL, Haines SJ, Taylor FH: Function of parietal and frontal shunts in childhood hydrocephalus. J Neurosurg 1988;69:883–886.
- Bierbrauer KS, Storrs BB, McLone DG, Tomita T, Dauser R: A prospective, randomized study of shunt function and infections as a function of shunt placement. Pediatr Neurosurg 1990;16:287–291.
- Dickerman RD, McConathy WJ, Morgan J, Stevens QE, Jolley JT, Schneider S, Mittler MA: Failure rate of frontal versus parietal approaches for proximal catheter placement in ventriculoperitoneal shunts: revisited. J Clin Neurosci 2005;12:781–783.
- Shah SS, Hall M, Slonim AD, Hornig GW, Berry JG, Sharma V: A multicenter study of factors influencing cerebrospinal fluid shunt survival in infants and children. Neurosurgery 2008;62:1095–1102, discussion 1102–1103.
- McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ: Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003;36:858–862.
- Pirotte BJ, Lubansu A, Bruneau M, Loqa C, van Cutsem N, Brotchi J: Sterile surgical technique for shunt placement reduces the shunt infection rate in children: preliminary analysis of a prospective protocol in 115 consecutive procedures. Childs Nerv Syst 2007;23:1251–1261.
- Vinchon M, Dhellemes P: Cerebrospinal fluid shunt infection: Risk factors and long-term follow-up. Childs Nerv Syst 2006;22: 692–697.
-
Gapminder. 2006. http://www.Gapminder.Org/data/.
-
CIA: The world fact book: country comparison. Infant mortality rate 2010. https://www.cia.gov/library/publications/the-world-fact book/rankorder/2091rank.html?country Name=Egypt&countryCode=EG®ion Code=af
- Choux M, Genitori L, Lang D, Lena G: Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992;77:875–880.
- Rotim K, Miklic P, Paladino J, Melada A, Marcikic M, Scap M: Reducing the incidence of infection in pediatric cerebrospinal fluid shunt operations. Childs Nerv Syst 1997;13:584–587.
- Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, Hamilton AJ: Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003;98:725–730.
Article / Publication Details
Received: February 15, 2010
Accepted: July 13, 2010
Published online: November 04, 2010
Issue release date: November 2010
Number of Print Pages: 6
Number of Figures: 4
Number of Tables: 2
ISSN: 1016-2291 (Print)
eISSN: 1423-0305 (Online)
For additional information: https://www.karger.com/PNE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
